H19 and gastric cancer: Additionally, Zhou et al. [45] evaluated the diagnostic utility of lncRNA -H19 level in gastric cancer and reported that with a diagnostic power of 0.838, lncRNA-H19 levels could differentiate between the patients with gastric carcinoma and the healthy controls.